A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to compare the efficacy, safety of DU-176b 30mg or DU-176b
15mg versus enoxaparin sodium for the prevention of venous thromboembolism in patients after
elective total hip arthroplasty.